MeiraGTx to Present at Upcoming Conferences
October 02, 2018 16:30 ET
|
MeiraGTx
LONDON and NEW YORK, Oct. 02, 2018 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that it will...
MeiraGTx Announces AAV-CNGA3 Granted Rare Pediatric Disease Designation by the U.S. FDA for the Treatment of Achromatopsia
August 27, 2018 08:00 ET
|
MeiraGTx
LONDON and NEW YORK, Aug. 27, 2018 (GLOBE NEWSWIRE) -- MeiraGTx Holdings Plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that the Offices...
MeiraGTx Announces AAV-CNGB3 Granted Fast Track Designation by U.S. FDA for Treatment of Achromatopsia
August 20, 2018 08:00 ET
|
MeiraGTx
LONDON and NEW YORK, Aug. 20, 2018 (GLOBE NEWSWIRE) -- MeiraGTx Holdings Plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that the U.S. Food...
MeiraGTx Announces AAV-CNGA3 Has Received Orphan Drug Designation from the U.S. FDA for the Treatment of Achromatopsia
August 13, 2018 07:00 ET
|
MeiraGTx
LONDON and NEW YORK, Aug. 13, 2018 (GLOBE NEWSWIRE) -- MeiraGTx Holdings Plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that the U.S. Food...
MeiraGTx Reports Second Quarter 2018 Financial Results and Provides Corporate Update
August 08, 2018 08:00 ET
|
MeiraGTx
LONDON and NEW YORK, Aug. 08, 2018 (GLOBE NEWSWIRE) -- MeiraGTx Holdings Plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial results for the...
MeiraGTx Receives Positive Opinion for Orphan Drug Designation in the European Union for AAV-CNGA3 for the Treatment of Achromatopsia
June 26, 2018 08:00 ET
|
MeiraGTx
LONDON and NEW YORK, June 26, 2018 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that the European...
MeiraGTx Announces MHRA Grants MIA (IMP) License for cGMP Manufacturing Facility in London, UK
June 21, 2018 08:00 ET
|
MeiraGTx
LONDON and NEW YORK, June 21, 2018 (GLOBE NEWSWIRE) -- MeiraGTx Holdings Plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced it has been granted a...
MeiraGTx Announces Closing of Initial Public Offering
June 12, 2018 17:44 ET
|
MeiraGTx
LONDON and NEW YORK, June 12, 2018 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq:MGTX), a vertically integrated, clinical stage gene therapy company, today announced the closing of its initial...
MeiraGTx Announces Pricing of Initial Public Offering
June 07, 2018 18:36 ET
|
MeiraGTx
LONDON and NEW YORK, June 07, 2018 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (the “Company”), a vertically integrated, clinical stage gene therapy company, today announced the pricing of its initial...